methyl 4-(difluoromethoxy)-3-nitrobenzoate, 250mg

1-Azido-2-methoxyethane (50% solution in Monoglyme), 1g

1,3,5-Tris(3-bromophenyl)benzene>96.0%(HPLC)5g

2-bromo-5-(methylthio)pyridine, 95.0%, 5g

1-(Difluoromethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one, 98%, 250mg

5-(bromomethyl)-3-ethyl-4,5-dihydroisoxazole, 95.0%, 10g

(5-FLUORO-6-METHYL-3-PYRIDYL)BORONIC ACID, 95%, 5g

(S)-2-((S)-2-AMINO-3-METHYLBUTANAMIDO)-5-UREIDOPENTANOIC ACID, 95%, 10mg

Ethyl 3-formylbenzoate, 95+%, 100mg

3-(4-bromophenyl)-2'-trifluoromethylpropiophenone, 97.0%, 1g

N,O-Bis(trimethylsilyl)acetamide Kit BSA 1 mL * 8 / Reaction vial, capacity 2 mL * 8>80.0%(GC)1kit

1-N-Boc-3-Cyano-pyrrolidine, 98.0%, 10g

9-Phenyl-3,6-bis[4-(1-phenylbenzimidazol-2-yl)phenyl]carbazole>98.0%(HPLC)200mg